“Off-the-shelf” cancer immunotherapy inches closer with new mouse study
Immunotherapy is a promising cancer treatment, but it can take too long to administer. In a new study, scientists at UCLA have taken steps towards an “off-the-shelf” therapy that could be mass produced and quickly rolled out to patients with a variety … Continue reading “Off-the-shelf” cancer immunotherapy inches closer with new mouse study